342 related articles for article (PubMed ID: 22850422)
1. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.
Conrad C; Gregorio J; Wang YH; Ito T; Meller S; Hanabuchi S; Anderson S; Atkinson N; Ramirez PT; Liu YJ; Freedman R; Gilliet M
Cancer Res; 2012 Oct; 72(20):5240-9. PubMed ID: 22850422
[TBL] [Abstract][Full Text] [Related]
2. Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer.
Huang XM; Liu XS; Lin XK; Yu H; Sun JY; Liu XK; Chen C; Jin HL; Zhang GE; Shi XX; Zhang Q; Yu JR
Cancer Sci; 2014 Feb; 105(2):150-8. PubMed ID: 24261990
[TBL] [Abstract][Full Text] [Related]
3. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
4. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
5. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
7. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
8. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
9. ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells.
Chen Q; Mo L; Cai X; Wei L; Xie Z; Li H; Li J; Hu Z
Int J Med Sci; 2018; 15(7):666-673. PubMed ID: 29910670
[TBL] [Abstract][Full Text] [Related]
10. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
11. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
Kornete M; Sgouroudis E; Piccirillo CA
J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid Dendritic Cells and ICOS
Liu X; Yu H; Yan C; Mei Y; Lin C; Hong Y; Lin X; Zhang Q; Yu J
J Cancer; 2019; 10(26):6711-6715. PubMed ID: 31777600
[No Abstract] [Full Text] [Related]
13. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection.
Redpath SA; van der Werf N; Cervera AM; MacDonald AS; Gray D; Maizels RM; Taylor MD
Eur J Immunol; 2013 Mar; 43(3):705-15. PubMed ID: 23319295
[TBL] [Abstract][Full Text] [Related]
14. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
[TBL] [Abstract][Full Text] [Related]
15. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
[TBL] [Abstract][Full Text] [Related]
16. ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis.
Lu LC; Deantonio C; Palu CC; Lee YH; Mitchell LS; Cowan M; Corser M; Sherry L; Cheng AL; Quaratino S; Shao YY; Sainson RCA; Hsu CH
Oncology; 2022; 100(8):419-428. PubMed ID: 35709702
[TBL] [Abstract][Full Text] [Related]
17. Circulating Treg cells from patients with cerebral aneurysms displayed deficiency in ICOS expression and function.
Zhao MG; Peng C; Li LM; Chen L; Zhang HF
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1923-1931. PubMed ID: 32726458
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
19. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.
Ito T; Hanabuchi S; Wang YH; Park WR; Arima K; Bover L; Qin FX; Gilliet M; Liu YJ
Immunity; 2008 Jun; 28(6):870-80. PubMed ID: 18513999
[TBL] [Abstract][Full Text] [Related]
20. ICOS-Deficient Regulatory T Cells Can Prevent Spontaneous Autoimmunity but Are Impaired in Controlling Acute Inflammation.
Chang J; Bouchard A; Bouklouch Y; Panneton V; Li J; Diamantopoulos N; Mohammaei S; Istomine R; Alvarez F; Piccirillo CA; Suh WK
J Immunol; 2022 Jul; 209(2):301-309. PubMed ID: 35760518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
